You are viewing the site in preview mode
Skip to main content
|
Outcomes
|
3-dose group (n = 27)
|
4-dose group (n = 27)
|
p-value
|
|---|
|
Anamnestic response
|
7 (25.9%)
|
9 (33.3%)
|
0.551
|
|
High-level responders at week 4
|
0 (0%)
|
1 (3.7%)
|
1.000
|
|
Responders at week 28
|
23 (85.2%)
|
24 (88.9%)
|
1.000
|
|
High-level responders at week 28
|
12 (44.4%)
|
17 (63.0%)
|
0.172
|
|
GMT of anti-HBs Ab at week 4 (95% CI)
|
4.4 (2.1–8.4)
|
5.29 (2.4–10.8)
|
0.714
|
|
GMT of anti-HBs Ab at week 28 (95% CI)
|
63.8 (31.4–128.7)
|
209.8 (90.0–487.4)
|
0.030
|
- CI confidence interval, GMT geometric mean titer